A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

(Reuters) -Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until ... compared with analyst forecasts of around $7.4 billion.

(Reuters) - Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for ...

Cervical cancer continues to be one of the leading causes of cancer-related deaths among women, and the Caribbean region has some of the highest rates of this disease in the ...

During health secretary nominee Robert F. Kennedy Jr.'s Jan. 29 Senate confirmation hearing, Sen. Elizabeth Warren, D-Mass., ...

Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at ... compared with analyst forecasts of around $7.4 billion. Total revenue rose to $15.6 billion from $14.6 ...